Evidence map›Paper›PMID 12205563›Full record

ArticleAmerican journal of human genetics2002

A gene mutated in nephronophthisis and retinitis pigmentosa encodes a novel protein, nephroretinin, conserved in evolution.

Edgar Otto, Julia Hoefele, Rainer Ruf, Adelheid M Mueller, Karl S Hiller, Matthias T F Wolf, Maria J Schuermann, Achim Becker, Ralf Birkenhäger, Ralf Sudbrak and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 208 citations in OpenAlex.

  1. Trial
  2. Syndromic Retinitis Pigmentosa: A Narrative Review.Vision (Basel, Switzerland) · 2025
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Kinase Inhibitors in Genetic Diseases.International journal of molecular sciences · 2023
    Review
  9. Clock genes rescue nphp mutations in zebrafish.Human molecular genetics · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Targeted broad-based genetic testing by next-generation sequencing informs diagnosis and facilitates management in patients with kidney diseases.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2021
    Article
  15. Renal Ciliopathies: Sorting Out Therapeutic Approaches for Nephronophthisis.Frontiers in cell and developmental biology · 2021
    Review
  16. Article
  17. Review
  18. Article
  19. Photoreceptor Cilia and Retinal Ciliopathies.Cold Spring Harbor perspectives in biology · 2017
    Review
  20. Article

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Edgar OttoDepartment of Pediatrics, University of Michigan, Ann Arbor, MI, USA.
Julia Hoefele
Rainer Ruf
Adelheid M Mueller
Karl S Hiller
Matthias T F Wolf
Maria J Schuermann
Achim Becker
Ralf Birkenhäger
Ralf Sudbrak
Hans C Hennies
Peter Nürnberg
Friedhelm Hildebrandt
University of Michigan–Ann Arbor · USMax Delbrück Center · DEMax Planck Institute for Molecular Genetics · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nephronophthisis (NPHP) comprises a group of autosomal recessive cystic kidney diseases, which constitute the most frequent genetic cause for end-stage renal failure in children and young adults. The most prominent histologic feature of NPHP consists of development of renal fibrosis, which, in chronic renal failure of any origin, represents the pathogenic event correlated most strongly to loss of renal function. Four gene loci for NPHP have been mapped to chromosomes 2q13 (NPHP1), 9q22 (NPHP2), 3q22 (NPHP3), and 1p36 (NPHP4). At all four loci, linkage has also been demonstrated in families with the association of NPHP and retinitis pigmentosa, known as "Senior-Løken syndrome" (SLS). Identification of the gene for NPHP type 1 had revealed nephrocystin as a novel docking protein, providing new insights into mechanisms of cell-cell and cell-matrix signaling. We here report identification of the gene (NPHP4) causing NPHP type 4, by use of high-resolution haplotype analysis and by demonstration of nine likely loss-of-function mutations in six affected families. NPHP4 encodes a novel protein, nephroretinin, that is conserved in evolution--for example, in the nematode Caenorhabditis elegans. In addition, we demonstrate two loss-of-function mutations of NPHP4 in patients from two families with SLS. Thus, we have identified a novel gene with critical roles in renal tissue architecture and ophthalmic function.

Indexed as

ProteinsAdaptor Proteins, Signal TransducingCarrier ProteinsCytoskeletal ProteinsHaplotypesHumansKidney Diseases, CysticMembrane ProteinsMolecular Sequence DataOrgan SpecificityRetinitis PigmentosaSequence Analysis, DNAAdaptor Proteins, Signal TransducingCarrier ProteinsCytoskeletal ProteinsMembrane ProteinsNPHP1 protein, humanNPHP4 protein, humanProteins

Identifiers

PMID12205563
PMCPMC385091
OpenAlexW2003260901

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.